These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1953220)
1. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count? Eisner MS; Lewis JH Arch Intern Med; 1991 Nov; 151(11):2180-4. PubMed ID: 1953220 [TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood testing for colorectal cancer screening: use the finger. Burke CA; Tadikonda L; Machicao V Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767 [TBL] [Abstract][Full Text] [Related]
3. Lower specificity of occult-blood test on stool collected by digital rectal examination. Zhang B; Nakama H; Fattah AS; Kamijo N Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640 [TBL] [Abstract][Full Text] [Related]
4. Digital fecal occult blood testing in the ambulatory urology clinic. Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580 [TBL] [Abstract][Full Text] [Related]
5. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
6. Digital rectal fecal occult blood screening during gynecologic examination. Willis FL; Fanning J Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856 [TBL] [Abstract][Full Text] [Related]
7. An audit of the utility of in-patient fecal occult blood testing. Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179 [TBL] [Abstract][Full Text] [Related]
8. Digital rectal examination versus spontaneous passage of stool for fecal occult blood testing. Ashraf I; Paracha SR; Arif M; Choudhary A; Matteson ML; Clark RE; Godfrey JD; Hammad HT; Bechtold ML South Med J; 2012 Jul; 105(7):357-61. PubMed ID: 22766663 [TBL] [Abstract][Full Text] [Related]
9. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Smith A; Young GP; Cole SR; Bampton P Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938 [TBL] [Abstract][Full Text] [Related]
11. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms. Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980 [TBL] [Abstract][Full Text] [Related]
13. Is routine fecal occult blood testing worthwhile in hospitalized patients? Anthea N; Afroze M; Richard W Md Med J; 1994 May; 43(5):443-5. PubMed ID: 8052096 [TBL] [Abstract][Full Text] [Related]
14. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592 [TBL] [Abstract][Full Text] [Related]
15. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center. Mahon SM Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy. Liu HH; Huang TW; Chen HL; Wang TH; Lin JT Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203 [TBL] [Abstract][Full Text] [Related]
18. A comparison of three stool tests for colorectal cancer screening. Greenwald B Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108 [TBL] [Abstract][Full Text] [Related]
19. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
20. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]